13F Pro

SEC Form 4 reporting owner

Bancel Stephane

Bancel Stephane has filed 17 Form 4 transactions reported between December 11, 2025 and August 6, 2026, as Chief Executive Officer of Moderna, Inc. and a reporting owner of Generate Biomedicines, Inc..

Name as filed: Bancel Stephane

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$28.7M
4 lines
Companies
2
with Form 4 filings
Latest transaction
Aug 6, 2026
transaction date

Roles and reported holdings

  • MRNAModerna, Inc.
    Dec 11, 2025 – Aug 6, 2026

    Chief Executive Officer

    Held directly6,187,791 sh as of Aug 5, 2026 · Form 4

    24 months: $28.7M sold

  • GENBGenerate Biomedicines, Inc.
    Feb 26, 2026 – Mar 2, 2026

    Reporting owner

    No common-stock holding reported on a purchase, sale, gift or withholding line.

Transaction history

All 17 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Aug 6, 2026MRNAChief Executive OfficerOption exerciseCode M · direct64,928—Form 4
Aug 6, 2026MRNAChief Executive OfficerOption exerciseCode M · direct187,541—Form 4
Aug 6, 2026MRNAChief Executive OfficerOption exerciseCode M · direct252,469$4.8M@ $19.15Form 4
Aug 5, 2026MRNAChief Executive OfficerOption exerciseCode M · direct128,393—Form 4
Aug 5, 2026MRNAChief Executive OfficerOption exerciseCode M · direct370,853—Form 4
Aug 5, 2026MRNAChief Executive OfficerOpen-market saleCode S · direct187,044$11.0M@ $58.79Form 4
Aug 5, 2026MRNAChief Executive OfficerOpen-market saleCode S · direct39,891$2.3M@ $58.12Form 4
Aug 5, 2026MRNAChief Executive OfficerOpen-market saleCode S · direct124,838$7.1M@ $56.96Form 4
Aug 5, 2026MRNAChief Executive OfficerOpen-market saleCode S · direct147,473$8.3M@ $56.21Form 4
Aug 5, 2026MRNAChief Executive OfficerOption exerciseCode M · direct499,246$9.6M@ $19.15Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect1,100,000—Form 4
Mar 2, 2026GENBConversion of derivativeCode C · indirect724,160—Form 4
Mar 1, 2026MRNAChief Executive OfficerGrant or awardCode A · direct250,932—Form 4
Feb 26, 2026GENBGrant or awardCode A · direct29,561—Form 4
Feb 11, 2026MRNAChief Executive OfficerShares withheld for tax or exercise priceCode F · direct5,450$229K@ $41.99Form 4
Feb 11, 2026MRNAChief Executive OfficerGrant or awardCode A · direct11,271—Form 4
Dec 11, 2025MRNAChief Executive OfficerOption exerciseCode M · direct688,073$7.5M@ $10.90Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.